-
Mashup Score: 0The Journal of Rheumatology: 50 (7) - 10 month(s) ago
July 01, 2023; Volume 50,Issue 7 Review Osteolysis in Systemic Sclerosis: A Scoping ReviewMiguel Gomes Guerra, Mariana Rodrigues, Ana Águeda, Joana Rodrigues, José Marona, António Violante and Margarida Oliveira The Journal of Rheumatology July 1 2023, 50 (7) 863-872; DOI:…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics - 11 month(s) ago
The complement system is a tightly regulated, cascading protein network representing a key component linking the innate and humoral immune systems. However, if misdirected or dysregulated, it can be similarly damaging to host-tissue. The role of complement dysregulation on vascular endothelial cells has been well established in atypical hemolytic uremic syndrome (aHUS), a thrombotic…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Expert Review The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics 📰 https://t.co/p7aug8Fejo #antiphospholipidsyndrome #neutrophilactivation #lupus #systemicsclerosis https://t.co/fzhW24Q3DQ
-
-
Mashup Score: 0Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades - 11 month(s) ago
AbstractObjective. We aimed to assess systemic sclerosis (SSc) mortality by age in the general population over the past five decades.Methods. This is a populati
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
Out now on Advance Access: The change in #SystemicSclerosis mortality rates over the past 5 decades https://t.co/9xuPUX1rhJ #SSc https://t.co/ZfY4iyAn9N
-
-
Mashup Score: 3
Objective We evaluated the epidemiology, manifestations, serology, comorbidities, and survival among patients with systemic sclerosis (SSc) with and without sarcoidosis. Methods We conducted a retrospective cohort study comparing patients with SSc with and without sarcoidosis. All patients fulfilled the American College of Rheumatology/European Alliance of Associations for Rheumatology…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Research Article Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome 📰 https://t.co/TPsp0lshsl #epidemiology #sarcoidosis #scleroderma #survival #systemicsclerosis https://t.co/V0oRMAuX7M
-
-
Mashup Score: 050th Year of Publication: Looking Back at the 1990s - 1 year(s) ago
This month I have selected 4 articles published in The Journal of Rheumatology during the 1990s that I feel are worthy of a second look by our readers. I have selected 4 articles, rather than my customary 3, as 2 of the articles are related and were published in the same issue of The Journal as companion articles from the same group and address measurements in ankylosing spondylitis. The…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
50th Volume Reprint Inter and Intraobserver Variability of Total Skin Thickness Score (Modified Rodnan TSS) in Systemic Sclerosis 📰 https://t.co/Bf2KdRUbkc #jrheum50 #reprints #systemicsclerosis https://t.co/K6ezReM6N2
-
-
Mashup Score: 050th Year of Publication: Looking Back at the 1990s - 1 year(s) ago
This month I have selected 4 articles published in The Journal of Rheumatology during the 1990s that I feel are worthy of a second look by our readers. I have selected 4 articles, rather than my customary 3, as 2 of the articles are related and were published in the same issue of The Journal as companion articles from the same group and address measurements in ankylosing spondylitis. The…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Editorial 50th Year of Publication: Looking Back at the 1990s 📰 https://t.co/pWPwu0WfjZ #ankylosingspondylitis #systemicsclerosis #stilldisease https://t.co/DSfIBpAj2J
-
-
Mashup Score: 0The Journal of Rheumatology: 50 (5) - 1 year(s) ago
May 01, 2023; Volume 50,Issue 5 Rheumatoid Arthritis Open Access Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid ArthritisClaire E.H. Barber, Diane Lacaille, Ruth…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Hello, May 🌷 View the full issue online 👉 https://t.co/8isvlNAmZT #osteoarthritis #rheumatoidarthritis #axialspondyloarthritis #psoriaticarthritis #lupus #systemicsclerosis #vasculitis #fibromyalgia #rheumatology #rheumtwitter #jrheum50 https://t.co/QbUxKzEZzo
-
-
Mashup Score: 0Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis - 1 year(s) ago
Objective To assess whether patient and physician global assessment of gastrointestinal tract (GIT) disease in systemic sclerosis (SSc) are associated with a meaningful change in disease status. Methods One hundred forty-three participants from the Australian Scleroderma Cohort Study were recruited to this study. Using logistic regression analysis, we evaluated the relationship between…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Research Article Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis 📰 https://t.co/TE1fw3nskr #assessments #gastrointestinal #systemicsclerosis https://t.co/STvgWAAOCv
-
-
Mashup Score: 1Research in Brief - 1 year(s) ago
The efficacy of baricitinib, a selective inhibitor of Janus kinase 1 and 2, in systemic lupus erythematosus (SLE) was inconclusive following two identically designed multicentre, double-blind, randomised, phase 3 trials (SLE-BRAVE-I and SLE-BRAVE-II). In both trials, adult patients with active SLE receiving stable background therapy were randomly assigned (1:1:1) to receive baricitinib 4 mg,…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet-
April Research in Brief featuring #SLE, #systemicsclerosis, #COVID19 and more! https://t.co/UpWldtw1ig https://t.co/X2p0K3c3eA
-
-
Mashup Score: 1Patient–researcher co-presentation of research results to people living with systemic sclerosis - 1 year(s) ago
Many people with rheumatic diseases participate in research, despite the burdens involved, to contribute to the wellbeing of others with rheumatic diseases, and most want to learn about the research results.1 Sharing results with patients generally, beyond study participants, might help to build trust in research, increase the likelihood of research participation, and contribute to supporting…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet-
New Correspondence in our April issue—Vanessa Cook and colleagues discuss an initiative for patient–researcher co-presentation of research results to people living with #systemicsclerosis https://t.co/D7kdSRxJDr @SclerodermaCAN @scleroderma_sso @LadyDavisJGH https://t.co/UgSksUYalx
-
Welcome July! ⛱️ View the full issue online 👉 https://t.co/rqHIll75N7 #systemicsclerosis #rheumatoidarthritis #spondyloarthritis #vasculitis #pediatric #patients #rheumatology #rheumtwitter #jrheum50 https://t.co/GiFQBUE9RZ